Skip to main content
Log in

Cmax/AUC, A Commentary

  • Commentary
  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCES

  1. L. Endrenyi and L. Tothfalusi. Secondary Metrics. J. Pharm. Sci. 86:401–402 (1997).

    Google Scholar 

  2. T. N. Tozer, F. Y. Bois, W. W. Hauck, M.-L. Chen, and R. L. Williams. Absorption rate vs. exposure: which is more useful for bioequivalence testing? Pharm Res. 13:453–456 (1996).

    Google Scholar 

  3. F. Y. Bois, T. N. Tozer, W. W. Hauck, M.-L. Chen, R. Patnaik, and R. L. Williams. Bioequivalence: Performance of several measures of rate of absorption. Pharm Res. 11:966–974 (1994).

    Google Scholar 

  4. M. Elze, H. Potthast, and H.H. Blume. Metrics of absorption. Data base analysis. In Bio-International 2, bioavailability, Bioequivalence and Pharmacokinetic Studies, H. H. Blume, and K. K. Midha, eds, Stuttgart, 1995, pp. 61–71.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thomas N. Tozer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tozer, T.N., Hauck, W.W. Cmax/AUC, A Commentary. Pharm Res 14, 967–968 (1997). https://doi.org/10.1023/A:1012128623213

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1012128623213

Navigation